GlassScriptPhysician profile
Nicholas Hanson
NPI 1356568661
$6,071.74
in general payments reported to CMS, 2019-2025
11 companies · $2,303 in 2025
The $2,303 reported for 2025 was more than what 76% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,076 · 2021: $10.45 · 2022: $378 · 2023: $336 · 2024: $968 · 2025: $2,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,512 · Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,511.57 |
| Food and Beverage | $1,095.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $2,302.99 | 2025 | Illuccix |
| Biocompatibles, INC. | $1,434.30 | 2019 | |
| Terumo Medical Corporation | $942.45 | 2023-2024 | Glidesheath Slender, Azur Cx Detachable |
| Boston Scientific Corporation | $543.03 | 2019 | |
| Cook Medical LLC | $388.80 | 2019-2024 | Rosen |
| Inari Medical, INC. | $188.61 | 2022 | |
| Penumbra, INC. | $154.11 | 2021-2024 | Indigo System |
| Teleflex LLC | $47.05 | 2023 | Supercross, Guideliner |
| Opsens INC. | $35.33 | 2019 | |
| Pfizer INC. | $18.88 | 2023 | |
| Ekos Corporation | $16.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.